{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:04:28Z","timestamp":1780596268707,"version":"3.54.1"},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Dupuytren Disease (DD) is a chronic progressive disease that can cause disabling hand deformities. The most common treatments have either high complication rates or high early recurrence rates. Dupuytren lacks a staging biomarker profile to inform the development of preventive therapeutics to improve long-term outcomes. This multi-omic study aimed to create a DD blood proteomic biomarker profile by comparing DD plasma with that of a healthy control group. We measured circulating collagen metabolism peptides and found normal Collagen I synthesis but impaired Collagen I degradation in DD. We measured 6995 serum protein aptamers and identified 68 proteins that showed statistically significant differences compared with the control group. We developed two Diagnostic Proteomic Risk Scores (DPRS) based on hypothesis-free and hypothesis-based analyses. In independent data, our hypothesis-free and hypothesis-based DPRS distinguished Dupuytren from control subjects with accuracies of 76.5% and 70.6%, respectively. Our hypothesis-based DPRS also distinguished DD subjects with different disease progression rates by age at their first corrective procedure (p\u2009=\u20090.0018). This pilot study is the first to provide evidence to suggest that Collagen I accumulation in DD results from impaired degradation rather than increased collagen synthesis. It also describes novel DPRS that have potential use as diagnostic and staging biomarker panels for Dupuytren disease.<\/jats:p>","DOI":"10.1371\/journal.pone.0343733","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:25:43Z","timestamp":1773854743000},"page":"e0343733","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of novel plasma proteomic biomarkers of Dupuytren disease"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7140-6499","authenticated-orcid":true,"given":"Blake","family":"Hummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-6701","authenticated-orcid":true,"given":"Anastasia","family":"Leshchyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-9397","authenticated-orcid":true,"given":"Anastasia","family":"Gurinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Bager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-3611","authenticated-orcid":true,"given":"Charles","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"4","key":"pone.0343733.ref001","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3111\/13696998.2012.670678","article-title":"Direct and indirect costs associated with Dupuytren\u2019s contracture","volume":"15","author":"D Macaulay","year":"2012","journal-title":"J Med Econ"},{"issue":"3","key":"pone.0343733.ref002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PRS.0000000000009919","article-title":"Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. a population-based cohort analysis","volume":"151","author":"DC Broekstra","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"pone.0343733.ref003","article-title":"Outcome of recurrent surgery in Dupuytren\u2019s disease: comparison with initial treatment","volume":"144","author":"NHA Mendelaar","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"pone.0343733.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhsa.2016.07.047","article-title":"Incidence of serious complications in hand surgery: a 10-year review","volume":"41","author":"AD Goodman","year":"2016","journal-title":"The J Hand Surg"},{"issue":"8","key":"pone.0343733.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhsa.2021.01.019","article-title":"Unplanned return to the operating room in upper-extremity surgery: incidence and reason for return","volume":"46","author":"L Schindelar","year":"2021","journal-title":"J Hand Surg Am"},{"key":"pone.0343733.ref006","article-title":"Surgical complications associated with fasciectomy for dupuytren\u2019s disease: a 20-year review of the English literature","volume":"10","author":"K Denkler","year":"2010","journal-title":"Eplasty"},{"issue":"1","key":"pone.0343733.ref007","doi-asserted-by":"crossref","first-page":"16520","DOI":"10.1038\/s41598-020-73595-y","article-title":"Serious complications and risk of re-operation after Dupuytren\u2019s disease surgery: a population-based cohort study of 121,488 patients in England","volume":"10","author":"O Alser","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0343733.ref008","first-page":"494","article-title":"Dupuytren\u2019s disease: a predominant reason for elective finger amputation in adults","volume":"109","author":"I Degreef","year":"2009","journal-title":"Acta Chir Belg"},{"issue":"2","key":"pone.0343733.ref009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1753193414535720","article-title":"Genetic and environmental influences in Dupuytren\u2019s disease: a study of 30,330 Danish twin pairs","volume":"40","author":"S Larsen","year":"2015","journal-title":"J Hand Surg Eur Vol"},{"issue":"4","key":"pone.0343733.ref010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren\u2019s disease","volume":"365","author":"GH Dolmans","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0343733.ref011","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PRS.0000000000005208","article-title":"A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren\u2019s disease","volume":"143","author":"SA Riesmeijer","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"pone.0343733.ref012","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-22697-7_21","article-title":"Dupuytren\u2019s Disease Shows Populations of Hematopoietic and Mesenchymal Stem-Like Cells Involving Perinodular Fat and Skin in Addition to Diseased Fascia: Implications for Pathogenesis and Therapy","volume-title":"Dupuytren\u2019s Disease and Related Hyperproliferative Disorders","author":"SA Iqbal","year":"2012"},{"issue":"3","key":"pone.0343733.ref013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/2000656X.2016.1140054","article-title":"Characterisation of the inflammatory response in Dupuytren\u2019s disease","volume":"50","author":"C Mayerl","year":"2016","journal-title":"J Plast Surg Hand Surg"},{"issue":"4","key":"pone.0343733.ref014","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/wrr.12928","article-title":"Biomimetic analyses of interactions between macrophages and palmar fascia myofibroblasts derived from Dupuytren\u2019s disease reveal distinct inflammatory cytokine responses","volume":"29","author":"BC Gonga-Cav\u00e9","year":"2021","journal-title":"Wound Repair Regen"},{"issue":"3","key":"pone.0343733.ref015","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0363-5023(94)90057-4","article-title":"Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren\u2019s disease","volume":"19","author":"NL Halliday","year":"1994","journal-title":"J Hand Surg Am"},{"issue":"4","key":"pone.0343733.ref016","first-page":"203","article-title":"Immunohistochemical expression and distribution of alpha2beta1, alpha6beta1, alpha5beta1 integrins and their extracellular ligands, type IV collagen, laminin and fibronectin in palmar fibromatosis","volume":"143","author":"G Magro","year":"1997","journal-title":"Gen Diagn Pathol"},{"issue":"6","key":"pone.0343733.ref017","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PRS.0000000000009115","article-title":"Disease course of primary Dupuytren disease: 5-year results of a prospective cohort study","volume":"149","author":"DC Broekstra","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"pone.0343733.ref018","volume-title":"Biochemistry of Collagens, Laminins and Elastin","author":"MA Karsdal","year":"2019"},{"issue":"1","key":"pone.0343733.ref019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","article-title":"Single-pot, solid-phase-enhanced sample preparation for proteomics experiments","volume":"14","author":"CS Hughes","year":"2019","journal-title":"Nat Protoc"},{"issue":"12","key":"pone.0343733.ref020","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199021","article-title":"R2-P2 rapid-robotic phosphoproteomics enables multidimensional cell signaling studies","volume":"15","author":"M Leutert","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"4","key":"pone.0343733.ref021","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s13361-018-2122-8","article-title":"Improving precursor selectivity in data-independent acquisition using overlapping windows","volume":"30","author":"D Amodei","year":"2019","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"pone.0343733.ref022","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/s41467-018-07454-w","article-title":"Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry","volume":"9","author":"BC Searle","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"pone.0343733.ref023","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1373\/clinchem.2011.173856","article-title":"Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures","volume":"58","author":"AN Hoofnagle","year":"2012","journal-title":"Clin Chem"},{"issue":"12","key":"pone.0343733.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"L Gold","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"pone.0343733.ref025","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/ijms24031899","article-title":"SOMAscan proteomics identifies novel plasma proteins in amyotrophic lateral sclerosis patients","volume":"24","author":"E Berrone","year":"2023","journal-title":"Int J Mol Sci"},{"key":"pone.0343733.ref026","author":"TCRA Network","year":"2023"},{"issue":"5","key":"pone.0343733.ref027","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"M Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"pone.0343733.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"D Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"pone.0343733.ref029","article-title":"Collagen.","volume-title":"Dupuytren\u2019s Disease Biology and Treatment","author":"AJ. Bailey","year":"1990","edition":"5"},{"issue":"5","key":"pone.0343733.ref030","first-page":"499","article-title":"Collagen of Dupuytren\u2019s disease","volume":"53","author":"AJ Bailey","year":"1977","journal-title":"Clin Sci Mol Med"},{"key":"pone.0343733.ref031","article-title":"Active synthesis of type I collagen homotrimer in Dupuytren\u2019s fibrosis is unaffected by anti-TNF-\u03b1 treatment","author":"K Williamson","year":"2023","journal-title":"bioRxiv preprint"},{"issue":"1","key":"pone.0343733.ref032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1980.tb00003.x","article-title":"Biochemistry and histology of the connective tissue of Dupuytren\u2019s disease lesions","volume":"10","author":"S Bazin","year":"1980","journal-title":"Eur J Clin Invest"},{"issue":"29","key":"pone.0343733.ref033","doi-asserted-by":"crossref","first-page":"22276","DOI":"10.1074\/jbc.M110.102079","article-title":"Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases","volume":"285","author":"S Han","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0343733.ref034","doi-asserted-by":"crossref","first-page":"303","DOI":"10.32098\/mltj.03.2014.07","article-title":"The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly","volume":"4","author":"JG Snedeker","year":"2014","journal-title":"Muscles Ligaments Tendons J"},{"issue":"5","key":"pone.0343733.ref035","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.PRS.0000081462.40448.49","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren\u2019s disease","volume":"112","author":"D Ulrich","year":"2003","journal-title":"Plast Reconstr Surg"},{"issue":"7","key":"pone.0343733.ref036","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/15589447241242818","article-title":"MMP-1, MMP-8, and MMP-13 gene polymorphisms and haplotype is a risk factor for Dupuytren contracture: a case-control study","volume":"20","author":"MP Rodrigues","year":"2025","journal-title":"Hand (N Y)"},{"key":"pone.0343733.ref037","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.matbio.2021.02.003","article-title":"A common SNP risk variant MT1-MMP causative for Dupuytren\u2019s disease has a specific defect in collagenolytic activity","volume":"97","author":"Y Itoh","year":"2021","journal-title":"Matrix Biol"},{"issue":"6","key":"pone.0343733.ref038","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbadis.2012.02.001","article-title":"MMP-14 and MMP-2 are key metalloproteases in Dupuytren\u2019s disease fibroblast-mediated contraction","volume":"1822","author":"JM Wilkinson","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"pone.0343733.ref039","doi-asserted-by":"crossref","DOI":"10.1186\/ar2315","article-title":"Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study","volume":"9","author":"P Krzeski","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"pone.0343733.ref040","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1242\/jcs.066795","article-title":"A new lock-step mechanism of matrix remodelling based on subcellular contractile events","volume":"123","author":"LF Castella","year":"2010","journal-title":"J Cell Sci"},{"issue":"7","key":"pone.0343733.ref041","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1258\/shorts.2012.012050","article-title":"The development of one-stop wide-awake dupuytren\u2019s fasciectomy service: a retrospective review","volume":"3","author":"Q Bismil","year":"2012","journal-title":"JRSM Short Rep"},{"issue":"1","key":"pone.0343733.ref042","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort","volume":"20","author":"LA Organ","year":"2019","journal-title":"Respir Res"},{"key":"pone.0343733.ref043","first-page":"105","article-title":"Molecular serum markers of liver fibrosis","volume":"7","author":"T Liu","year":"2012","journal-title":"Biomark Insights"},{"issue":"1","key":"pone.0343733.ref044","doi-asserted-by":"crossref","first-page":"100178","DOI":"10.1016\/j.jhepr.2020.100178","article-title":"Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease","volume":"3","author":"M Vesterhus","year":"2020","journal-title":"JHEP Rep"},{"issue":"9","key":"pone.0343733.ref045","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1681\/ASN.V1091891","article-title":"High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta","volume":"10","author":"DC Han","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"pone.0343733.ref046","doi-asserted-by":"crossref","first-page":"117420","DOI":"10.1016\/j.atherosclerosis.2023.117420","article-title":"Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death","volume":"388","author":"F Genovese","year":"2024","journal-title":"Atherosclerosis"},{"key":"pone.0343733.ref047","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2474-12-113","article-title":"Reversal of TGF-\u03b21 stimulation of \u03b1-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren\u2019s-derived fibroblasts","volume":"12","author":"L Satish","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"pone.0343733.ref048","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13069-016-0046-0","article-title":"Matrix and cell phenotype differences in Dupuytren\u2019s disease","volume":"9","author":"MM van Beuge","year":"2016","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"8","key":"pone.0343733.ref049","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhsa.2023.02.003","article-title":"Pharmacotherapies in Dupuytren disease: current and novel strategies","volume":"48","author":"AG Lambi","year":"2023","journal-title":"J Hand Surg Am"},{"issue":"8","key":"pone.0343733.ref050","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/ced.12424","article-title":"The prevalence of Dupuytren contractures in patients with psoriasis","volume":"39","author":"M Patel","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"pone.0343733.ref051","first-page":"574","article-title":"Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkers","volume":"41","author":"S Holm Nielsen","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"pone.0343733.ref052","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/978-3-642-78517-7_10","article-title":"Biochemical Parameters for the Diagnosis of Dupuytren\u2019s Disease.","volume-title":"Dupuytren\u2019s Disease Pathobiochemistry and Clinical Management","author":"N Gassier","year":"1994"},{"issue":"2","key":"pone.0343733.ref053","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/adt.2017.820","article-title":"Development of a neo-epitope specific assay for serological assessment of type VII collagen turnover and its relevance in fibroproliferative disorders","volume":"16","author":"JMB Sand","year":"2018","journal-title":"Assay Drug Dev Technol"},{"issue":"34","key":"pone.0343733.ref054","doi-asserted-by":"crossref","first-page":"20753","DOI":"10.1073\/pnas.2004281117","article-title":"Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP\/EP300","volume":"117","author":"LM Williams","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pone.0343733.ref055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhsa.2007.11.010","article-title":"Molecular phenotypic descriptors of Dupuytren\u2019s disease defined using informatics analysis of the transcriptome","volume":"33","author":"S Rehman","year":"2008","journal-title":"J Hand Surg Am"},{"issue":"20","key":"pone.0343733.ref056","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.yexcr.2009.07.015","article-title":"Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren\u2019s disease and adjacent palmar fascia cells","volume":"315","author":"L Vi","year":"2009","journal-title":"Exp Cell Res"},{"issue":"1","key":"pone.0343733.ref057","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-4-14","article-title":"Elevated transforming growth factor \u03b2 and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren\u2019s disease fibroblasts","volume":"4","author":"C Krause","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"3","key":"pone.0343733.ref058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059056","article-title":"Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren\u2019s disease","volume":"8","author":"HB Forrester","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"pone.0343733.ref059","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ajhg.2017.08.006","article-title":"A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis","volume":"101","author":"M Ng","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"2","key":"pone.0343733.ref060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/wrr.12774","article-title":"A meta-analysis to identify novel diagnostic and therapeutic targets for Dupuytren\u2019s disease","volume":"28","author":"TH Park","year":"2020","journal-title":"Wound Repair Regen"},{"issue":"10","key":"pone.0343733.ref061","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target","volume":"110","author":"LS Verjee","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0343733.ref062","first-page":"148","article-title":"Dupuytren Disease.","volume-title":"Green\u2019s Operative Hand Surgery","author":"C. Eaton","year":"2022","edition":"8"},{"issue":"28","key":"pone.0343733.ref063","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz8272","article-title":"Attenuation of Dupuytren\u2019s fibrosis via targeting of the STAT1 modulated IL-13R\u03b11 response","volume":"6","author":"M Akbar","year":"2020","journal-title":"Sci Adv"},{"issue":"7","key":"pone.0343733.ref064","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/intimm\/dxad004","article-title":"Dupuytren\u2019s contracture-associated SNPs increase SFRP4 expression in non-immune cells including fibroblasts to enhance inflammation development","volume":"35","author":"H Kida","year":"2023","journal-title":"Int Immunol"},{"issue":"1","key":"pone.0343733.ref065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41467-023-44451-0","article-title":"A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren\u2019s disease","volume":"15","author":"SA Riesmeijer","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"pone.0343733.ref066","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.4049\/jimmunol.1402800","article-title":"Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor","volume":"194","author":"HS Schultz","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"pone.0343733.ref067","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1091\/mbc.e06-09-0833","article-title":"Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking","volume":"18","author":"JC Bakowska","year":"2007","journal-title":"Mol Biol Cell"},{"issue":"6","key":"pone.0343733.ref068","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/J.JHSB.2005.06.008","article-title":"Epidermal growth factor receptor (EGF-R) in Dupuytren\u2019s disease","volume":"30","author":"K Augoff","year":"2005","journal-title":"J Hand Surg Br"},{"issue":"3","key":"pone.0343733.ref069","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jor.25059","article-title":"Circulating inflammatory cytokines alter transcriptional activity within fibrotic tissue of Dupuytren\u2019s disease patients","volume":"40","author":"ML Wang","year":"2022","journal-title":"J Orthop Res"},{"key":"pone.0343733.ref070","volume-title":"Dupuytren\u00b4s contracture: features and consequences","author":"S Wilbrand","year":"2002"},{"issue":"3","key":"pone.0343733.ref071","article-title":"Dupuytren\u2019s disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from the U.K. Clinical Practice Research Datalink","volume":"145","author":"RYL Kuo","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"pone.0343733.ref072","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PRS.0b013e31823aea95","article-title":"Five-year results of a randomized clinical trial on treatment in Dupuytren\u2019s disease: percutaneous needle fasciotomy versus limited fasciectomy","volume":"129","author":"AL van Rijssen","year":"2012","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"pone.0343733.ref073","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1054\/JHSB.1999.0154","article-title":"The sex ratio and rate of reoperation for Dupuytren\u2019s contracture in men and women","volume":"24","author":"S Wilbrand","year":"1999","journal-title":"J Hand Surg Br"},{"issue":"2","key":"pone.0343733.ref074","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14744\/tjtes.2024.95049","article-title":"The epidemiological, etiological, and clinical comparisons of primary and recurrent Dupuytren\u2019s contractures","volume":"31","author":"E Kozano\u011flu","year":"2025","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"issue":"4","key":"pone.0343733.ref075","article-title":"Collagenase Clostridium histolyticum versus needle fasciotomy for primary metacarpophalangeal dupuytren contracture: five-year results from a randomized controlled trial","volume":"9","author":"IT Hauksson","year":"2024","journal-title":"JB JS Open Access"},{"key":"pone.0343733.ref076","article-title":"Progression of Dupuytren\u2019s contracture: a randomized controlled trial comparing surgery, needle fasciotomy, and collagenase injection","author":"V-L Karjalainen","year":"2025","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"pone.0343733.ref077","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbadis.2013.04.018","article-title":"IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren\u2019s disease","volume":"1832","author":"C Raykha","year":"2013","journal-title":"Biochim Biophys Acta"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:25:58Z","timestamp":1773854758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343733"}},"subtitle":[],"editor":[{"given":"Luis A","family":"Arr\u00e1ez-Aybar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":77,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343733","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}